Events

Innovative Health Initiative Call Days & Matchmaking Events - Call 3
DEC
Mon
12
DEC
Tue
13
DEC
Wed
14
DEC
Thu
15

This was 2 years ago

Location

Online

Programmes
Health

The Innovative Health Initiative (IHI) has recently published draft information on future calls ahead of official publication to give applicants additional time to prepare a strong proposal. Find more information here

The upcoming IHI Call Days will provide potential applicants with the information they need to put together a strong proposal, and give them the opportunity to identify and meet partners for their consortia.

In the series covering Call 3, the following webinars are scheduled:

You can hold matchmaking meetings via the platform at any time until the deadline for submitting proposals.

More information and registration on the IHI website

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.